Theriva Biologics, Inc. (TOVX) Net income 2016–2025
Theriva Biologics, Inc. (TOVX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$23.7MFY2025 · since FY2016: -$27.3M → -$23.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.7M | +7.5% |
| FY2024 | -$25.7M | -39.8% |
| FY2023 | -$18.3M | +6.8% |
| FY2022 | -$19.7M | -38.0% |
| FY2021 | -$14.3M | -42.1% |
| FY2020 | -$10.0M | +34.4% |
| FY2019 | -$15.3M | -14.5% |
| FY2018 | -$13.4M | +11.9% |
| FY2017 | -$15.2M | +44.3% |
| FY2016 | -$27.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice